Kite Pharma, Inc. Proceeds from Stock Plans
Kite Pharma, Inc. reported Proceeds from Stock Plans of $1.21 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2017-02-28
- Kite Pharma, Inc. proceeds from stock plans for fiscal 2016 was $1.21M, a 105.42% increase from fiscal 2015.
- Kite Pharma, Inc. proceeds from stock plans for fiscal 2015 was $590.00K.
- Kite Pharma, Inc. proceeds from stock plans for fiscal 2014 was $0.00.
| Period end | Proceeds from Stock Plans 12 month |
|---|---|
| 2016-12-31 | $1.21M 10-K · filed 2017-02-28 |
| 2015-12-31 | $590.00K 10-K · filed 2017-02-28 |
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |